UTI Innovation Fund Analyst Review: NAV, Returns and Key Insights 2026

The UTI Innovation Fund has faced headwinds in the past year with a return of -3.41%, though a 3-month return of 10.13% suggests some recovery momentum. Managing Rs 739.73 crore in assets at a NAV of Rs 11.06, this review assesses the full performance picture, costs, risks, and investment suitability for 2026.

Click Here – Get Mutual Fund Advisory

What Is the UTI Innovation Fund?

The UTI Innovation Fund is classified as a Sectoral/Thematic equity fund, investing in companies aligned with a specific sector or economic theme. The concentrated nature of such funds can drive strong outperformance when the underlying theme is in favour but can also amplify losses during sector downturns. The fund carries a Very High risk rating and should be treated as a tactical allocation rather than a core holding.

UTI Innovation Fund NAV and AUM

The current NAV of the UTI Innovation Fund Direct Growth plan is Rs 11.06. NAV is updated each trading day and reflects the closing market prices of the fund’s underlying securities. Always verify the most recent NAV on the AMC website or a registered mutual fund platform before placing any transaction.

With an AUM of Rs 739.73 crore, the fund is relatively nimble. This can be advantageous for portfolio agility and the ability to take positions without significant market impact. Investors should track AUM trends alongside performance metrics when evaluating this fund.

UTI Innovation Fund Returns: Performance Snapshot

Period	Returns
1 Month	5.56%
3 Months	10.13%
1 Year	-3.41%
3 Years (Annualised)	Not Available
5 Years (Annualised)	Not Available

Performance has been under pressure for the UTI Innovation Fund with a 1-year return of -3.41%. The 3-month return of 10.13% provides some near-term context. While recovery phases do follow periods of underperformance in cyclical themes, investors should assess the fundamental outlook objectively and not rely solely on mean-reversion expectations when making an allocation decision.

Expense Ratio and Cost Efficiency

At 0.99% per annum, the expense ratio of the UTI Innovation Fund Direct Growth plan is moderate for its peer group. The direct plan remains more cost-efficient than the regular variant. Investors should factor the total cost of ownership into their long-term return calculations and compare across category peers before making a final decision.

Who Should Invest in UTI Innovation Fund?

Investors confident in the long-term prospects of the UTI Innovation Fund’s underlying investment theme can consider allocating to this fund as part of a satellite strategy. A minimum 5 to 7-year horizon and Very High risk tolerance are essential. The minimum SIP is Rs 500 and minimum lumpsum is Rs 5000. Conservative and first-time investors should avoid this fund entirely.

Key Risks to Consider

Timing Risk: Entry at peak valuations during a theme’s popularity can result in extended periods of underperformance. Thematic funds are highly sensitive to investor entry and exit timing.

Regulatory Risk: Sectors such as defence, pharma, and energy can be significantly impacted by government policy changes or regulatory shifts that are difficult to predict in advance.

Theme Obsolescence: Investment themes may lose relevance due to technological disruption, changing consumer behaviour, or structural shifts in the underlying industry.

Concentration Risk: Funds with a focused investment mandate are more vulnerable to segment-specific headwinds than broadly diversified equity schemes.

Download the Univest iOS App or Univest Android App to track this fund’s live NAV and manage your portfolio.

Conclusion

The UTI Innovation Fund has faced a difficult performance period with a 1-year return of -3.41%. Its expense ratio of 0.99% and AUM of Rs 739.73 crore remain its structural anchors. Investors should closely evaluate whether the fundamental investment thesis remains intact before holding, adding, or exiting. Consult a SEBI-registered investment advisor before making any decision.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.

Frequently Asked Questions

What is the current NAV of UTI Innovation Fund?

Ans. The current NAV of the UTI Innovation Fund Direct Growth plan is Rs 11.06. NAV is updated each trading day and reflects the closing market value of the fund’s underlying holdings. Always verify the most recent NAV on the AMC website or a SEBI-registered mutual fund platform before transacting.

What are the returns of UTI Innovation Fund?

Ans. The fund has delivered a 1-year return of -3.41% and a 3-month return of 10.13%. The 3-year annualised return is Not Available and the 5-year annualised return is Not Available. Past performance does not guarantee future results and should be evaluated alongside the fund’s risk profile and benchmark comparison.

What is the expense ratio of UTI Innovation Fund Direct Growth?

Ans. The expense ratio of the UTI Innovation Fund Direct Growth plan is 0.99% per annum. The direct plan eliminates distributor commissions and is more cost-efficient than the regular plan. Investors should always opt for the direct plan to maximise long-term net returns through the compounding advantage of lower costs.

Is this fund suitable for conservative investors?

Ans. No. This fund carries a Very High risk rating due to concentrated exposure to a specific market segment or investment theme. It is not suitable for conservative investors or those with short investment timelines. A minimum 5 to 7-year horizon and a high risk tolerance are required prerequisites. Consult a SEBI-registered investment advisor before investing.

What is the minimum SIP amount for this fund?

Ans. The minimum monthly SIP is Rs 500 and the minimum lumpsum investment is Rs 5000. The low entry thresholds make the fund accessible across income levels. A regular SIP approach is recommended to average out entry costs over time, particularly given the high-volatility nature of this fund’s category.

What category and sub-category does this fund belong to?

Ans. This fund is a Sectoral/Thematic equity fund with a focused portfolio aligned to a specific sector or theme. It falls under the Sectoral / Thematic sub-category and is available as a direct growth plan, which eliminates distributor commissions and typically offers superior net returns compared to the regular plan.